Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Nancy McKinney who wrote (5956)	11/20/1998 10:33:00 AM
From: Linda Kaplan	Respond to of 7041

Don't listen to hype, Nancy. Zero sales is zero sales. If it were a fact, rather than a lie, that Vasomax had 35% of the sales, the hypesters would be able to provide figures to back up that statement. It's a lie. The Vasomax sales in Mexico are VERY bad, and they will be just as bad anywhere else -- if it's approved anywhere else, which is questionable. Do you follow any systematic approach to your investing? If you're talking about averaging down now that the stock is at 18, why didn't you average down recently when it was at 12? Gosh, you're going to be killed in this stock. I sure hate to see that. These people are conning you. A stock that was 40 recently, now is 18. That is not "holding its own" in this bull run of a stock market. That's more than a 50% loss in value. Look at the lies you're being fed. --Linda

To: Nancy McKinney who wrote (5956)	11/20/1998 11:37:00 AM
From: Dauntless	Read Replies (1) \| Respond to of 7041

Nancy - In answer to your question I called IR and was told the following 1- A small trial of the oral product in women was conducted under the Vasomax IND. 2- A small dosage study has been conducted in Mexico. 3- An IND study on the feminine product will start before year end. This information has been freely discussed at public meetings for months. If you believe, as I do, that this company is well positioned (product-wise), financed and managed, then this would be a good time to pick some up. Oh, I guess it's time to update the scorecard for Zonagen vs. the screaming shorts. Zonagen will NEVER get a marketing partner - they did Zonagen will NEVER get a patent for Vasomax - they did Zonagen will NEVER get a patent for Chitosan - they did Zonagen will NEVER file their NDA - they did Zonagen will NEVER buy back a single share of their stock - they did Zonagen will NEVER have appreciable sales in Mexico - they did Zonagen will NEVER get their NDA accepted - they did Zonagen is a one product company - viva VASOMAXINE!!! The facts are hell, huh??